Merck invests in largest specialty gases facility in Hometown, PA.

Agreement with the Commonwealth of Pennsylvania supports expansion of manufacturing capacities for the semiconductor industry The roughly € 300 mil...

April 14, 2023 | Friday | News
Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the init...

April 14, 2023 | Friday | News
Araris Biotech AG Announces Strategic Investment with Samsung Ventures

Samsung Ventures makes investment in Araris Proceeds will be used to support further development and advancement of Araris’ antibody-drug conjugat...

April 12, 2023 | Wednesday | News
Thermo Fisher Scientific Expansion in France Boosts Capabilities from Development to Commercial Manufacturing

Thermo Fisher Scientific, the world leader in serving science, is adding early development work for oral solid dose therapies to its Bourgoin, France site,...

April 07, 2023 | Friday | News
RespireRx Pharmaceuticals collaborates with University College London to study AMPAkines for GRIA disorder treatment

RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of inn...

April 06, 2023 | Thursday | News
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease

Data shows reduction of microglia activation and improvement in behavior in rodent model of Alzheimer’s disease (AD) Modulation of neuroinflammati...

March 31, 2023 | Friday | News
Granular Therapeutics speeds up development of mast cell disease pipeline.

Dermatology industry veteran Thibaud Portal, PhD appointed as CEO  Granular Therapeutics, (Granular) a private biotech company specialising in p...

March 30, 2023 | Thursday | News
LG Chem Completes Acquisition of AVEO Oncology

“We are excited to complete LG Chem’s acquisition of AVEO, which will position us to deliver on our mission of becoming one of the world’...

January 24, 2023 | Tuesday | News
Integral Molecular Reveals Mechanism Underlying Exquisite Specificity of Claudin 6 Therapeutic Antibody Being Developed for Solid Tumors

Integral Molecular, the industry leader in antibody discovery for membrane proteins, has published the targeting mechanism enabling best-in-class specifici...

January 06, 2023 | Friday | News
Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate

The BENEGENE-2 study met its primary endpoint of non-inferiority and superiority in the annualized bleeding rate (ABR) of total bleeds post-fidanacogene el...

January 02, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close